The board has recommended a final dividend payout of Rs 1.50 per share. In FY23, Biocon’s revenue grew almost 37% to Rs 11,174 crore, while its net profit fell nearly 29% to Rs 463 crore. The biosimilars business segment more than doubled its year-on-year revenue to INR2,102 crore in Q4 2022.
Oil rises, US futures drop on Trump Tehran warning
President Trump’s call for evacuating Tehran amid the Israel-Iran conflict rattled global markets, causing US futures to fall and oil prices to climb. This statement